ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

News from the ECOG-ACRIN Cancer Research Group
August 28, 2025
Dr. O'Dwyer and Dr. Schnall
August 28, 2025
Categories
  • From the Co-Chairs

From the Co-Chairs, August 2025

An open letter from the NCTN Cooperative Group Chairs to Congress on the importance of supporting robust federal funding for cancer research
Do you like it?
0 Read more
August 28, 2025
August 28, 2025
Categories
  • Active Clinical Trials

Now Enrolling: EAA241 Study for Patients With Newly Diagnosed Multiple Myeloma and Kidney Failure

This clinical trial aims to improve outcomes by utilizing novel myeloma targeting therapy to reverse kidney failure
Do you like it?
0 Read more
August 28, 2025
August 28, 2025
Categories
  • Special Topics

Building a Lasting Bond: Your Oncologist as Partner Through Good and Bad Times

Four tips for creating and maintaining a strong patient-oncologist relationship
Do you like it?
0 Read more
August 28, 2025
August 28, 2025
Categories
  • Active Clinical Trials

Amended Trial: David Weinberg Gives an Update on the EA2185 Study for Patients with Non-Cancerous Pancreatic Cysts

This study is now assessing blood-based and imaging biomarkers to identify patients at elevated risk of pancreatic cysts becoming cancerous
Do you like it?
0 Read more
August 28, 2025
Research definition
August 28, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN Research Round-Up

The latest clinical trial findings in breast cancer, leukemia, NCI-MATCH precision medicine, penile cancer, and prostate cancer
Do you like it?
0 Read more
August 28, 2025
News in Brief
August 28, 2025
Categories
  • News in Brief

News in Brief, August 2025

Timely information about research presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org

Tags

Acute lymphoblastic leukemia (ALL) Advanced practice providers Advocacy ASCO Breast cancer Cancer care delivery research Cancer control Cancer screening Cancer surveillance Chemotherapy Clinical trials Comis Symposium Communication COVID-19 GI cancer Group Meeting Head and neck cancer Head and neck squamous cell carcinoma Health equity Immunotherapy In memory Kidney cancer Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Myeloma NCI NCI-MATCH NCORP Non-small cell lung cancer Pancreatic cancer Pancreatic cyst Patient-reported outcomes Precision medicine Prevention Prostate cancer Real-world data Research results Sarcoma Survivorship Targeted therapy TMIST
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2025 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc